Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Brooks Gentry

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Toxicology and Applied Pharmacology|May 27, 2005
Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in ratsAlessandra Milesi-Hallé, Howard P Hendrickson, Elizabeth M Laurenzana, et al.
CNS & Neurological Disorders Drug Targets|January 11, 2012
Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addictionS Michael Owens, William T Atchley, Michael D Hambuchen, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2010
The fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of ratsJonathan J Hubbard, Elizabeth M Laurenzana, D Keith Williams, et al.
European Journal of Pharmacology|September 27, 2005
Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in ratsKelly A Byrnes-Blake, Elizabeth M Laurenzana, Reid D Landes, et al.
European Journal of Pharmacology|March 26, 2013
Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedureAlison Oliveto, Michael Mancino, Nichole Sanders, et al.
Journal of Clinical Psychopharmacology|September 12, 2009
Open-label pilot study of modafinil for methamphetamine dependenceJanette McGaugh, Michael J Mancino, Zachary Feldman, et al.
Pharmacology, Biochemistry, and Behavior|December 8, 2004
(+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administrationW Brooks Gentry, Abid U Ghafoor, William D Wessinger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2003
Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in ratsElizabeth M Laurenzana, Kelly A Byrnes-Blake, Alessandra Milesi-Hallé, et al.
Clinical Pharmacology and Therapeutics|May 19, 2005
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypesBill J Gurley, Stephanie F Gardner, Martha A Hubbard, et al.
International Immunopharmacology|April 29, 2006
Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in ratsW Brooks Gentry, Elizabeth M Laurenzana, D Keith Williams, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Toxicology and Applied Pharmacology|May 27, 2005
Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in ratsAlessandra Milesi-Hallé, Howard P Hendrickson, Elizabeth M Laurenzana, et al.
CNS & Neurological Disorders Drug Targets|January 11, 2012
Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addictionS Michael Owens, William T Atchley, Michael D Hambuchen, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2010
The fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of ratsJonathan J Hubbard, Elizabeth M Laurenzana, D Keith Williams, et al.
European Journal of Pharmacology|September 27, 2005
Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in ratsKelly A Byrnes-Blake, Elizabeth M Laurenzana, Reid D Landes, et al.
European Journal of Pharmacology|March 26, 2013
Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedureAlison Oliveto, Michael Mancino, Nichole Sanders, et al.
Journal of Clinical Psychopharmacology|September 12, 2009
Open-label pilot study of modafinil for methamphetamine dependenceJanette McGaugh, Michael J Mancino, Zachary Feldman, et al.
Pharmacology, Biochemistry, and Behavior|December 8, 2004
(+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administrationW Brooks Gentry, Abid U Ghafoor, William D Wessinger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2003
Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in ratsElizabeth M Laurenzana, Kelly A Byrnes-Blake, Alessandra Milesi-Hallé, et al.
Clinical Pharmacology and Therapeutics|May 19, 2005
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypesBill J Gurley, Stephanie F Gardner, Martha A Hubbard, et al.
International Immunopharmacology|April 29, 2006
Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in ratsW Brooks Gentry, Elizabeth M Laurenzana, D Keith Williams, et al.
Pageof 3